Authors
Latest:
Artificial Intelligence in Oncology: Current Applications and Future DirectionsIn this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.
Latest:
Artificial Intelligence in Oncology: Current Applications and Future DirectionsIn this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.
Latest:
Artificial Intelligence in Oncology: Current Applications and Future DirectionsIn this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.
Latest:
Artificial Intelligence in Oncology: Current Applications and Future DirectionsIn this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.
Latest:
Pancreatic Cancer Incidence Has Risen, Yet Survival Outcomes Have ImprovedPancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Latest:
Using Genetics to Determine Disparities in Gastric CancerCancer Network spoke with Dr. Shaila Merchant about the difficulty in determining and linking the many disparities in gastric cancer and how genetic research can help.
Latest:
Prolong Adjuvant Aromatase Inhibitor Therapy in Breast Cancer?Cancer Network spoke with Richard Gray, MSc, about the effects of prolonging adjuvant aromatase inhibitor therapy has on breast cancer patients.
Latest:
Exercise Effects on Depressive Symptoms in Cancer PatientsCancer Network speaks with an exercise physiologist about the benefits of physical activity for depressed and anxious cancer patients.
Latest:
Exercise Effects on Depressive Symptoms in Cancer PatientsCancer Network speaks with an exercise physiologist about the benefits of physical activity for depressed and anxious cancer patients.
Latest:
Decreasing Clinical Trial Participation BarriersCancer Network speaks with Joseph Unger, PhD, about ways to decrease the barriers for cancer patients to enroll in clinical trials.
Latest:
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementThis review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
Latest:
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementThis review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
Latest:
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementThis review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
Latest:
New Developments in Neoadjuvant Therapy for Lung CancerIn this article, we review the new developments in neoadjuvant therapy for lung cancer.
Latest:
New Developments in Neoadjuvant Therapy for Lung CancerIn this article, we review the new developments in neoadjuvant therapy for lung cancer.
Latest:
New Developments in Neoadjuvant Therapy for Lung CancerIn this article, we review the new developments in neoadjuvant therapy for lung cancer.
Latest:
Novel Targets and Precision Medicine for Prostate Cancer-Part 2: Tumor Profiling and Personalized Therapy in Patients With Castration-Resistant Prostate CancerIn this article, we review the current use of and future direction for genetic testing and tumor profiling in patients with metastatic castration-resistant prostate cancer.
Latest:
A Patient With Pure Teratoma of the Testis Presenting With an Anterior Mediastinal MassA 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?
Latest:
A Patient With Pure Teratoma of the Testis Presenting With an Anterior Mediastinal MassA 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?
Latest:
A Patient With Pure Teratoma of the Testis Presenting With an Anterior Mediastinal MassA 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?
Latest:
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementThis review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
Latest:
Role of Chemopreventive Agents in Women at Increased Risk for Breast CancerCancer Network spoke with Charles Shapiro, MD, about the USPSTF's stance on use of tamoxifen, raloxifene, and aromatase inhibitors to prevent breast cancer.
Latest:
Regorafenib for Metastatic Colorectal Cancer: Common Toxicities and Prevention StrategiesAn oncology pharmacist discusses how to prevent and treat the toxicities from regorafenib for the treatment of colorectal cancer.
Latest:
Multiple Myeloma With Extramedullary Disease: A Challenging Clinical DilemmaA 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?
Latest:
Multiple Myeloma With Extramedullary Disease: A Challenging Clinical DilemmaA 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?
Latest:
Multiple Myeloma With Extramedullary Disease: A Challenging Clinical DilemmaA 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?
Latest:
What to Do When Anti–PD-1 Therapy Fails in Patients With MelanomaThis review summarizes the current available treatment strategies for patients with advanced melanoma when PD-1–directed therapy is not enough.
Latest:
Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged TumorsIn this article, important concepts in the molecular testing of non–small-cell lung cancer are highlighted.
Latest:
Looking to Agriculture Strategies to Manage Drug Resistance in CancerCancer Network spoke with Carlo Maley, PhD, about how strategies utilized in agriculture can be applied to drug resistance in oncology.
Latest:
Targeting the Metastatic Tumor Microenvironment to Limit Cancer ProgressionCancer Network spoke with Sheila A. Stewart, PhD, on how age-related changes in the tumor microenvironment may impact progression and metastasis.
